XNK Therapeutics appoints Michael Uhlin as Chief Scientific Officer
News provided by
Share this article
STOCKHOLM, April 20, 2021 /PRNewswire/
XNK Therapeutics AB ( XNK ) today announced the appointment of Professor Michael Uhlin as Chief Scientific Officer, effective August 1
st. He will be a member of the company s management team.
Michael Uhlin, PhD, will be responsible for defining, implementing, and developing the company s scientific strategy. He will lead a team involved in R&D and manufacturing with focus on platform development as well as improving production processes and executing operational research plans.
Professor Uhlin received his master s degree in medical research with a focus on biomedicine from Karolinska Institutet (KI) in 2002 and his PhD in Infection Biology from KI in 2006. Since then, he has held several senior positions primarily within clinical immunology and cellular therapy at KI and Karolinska University Hospital, Stockholm, including serving
Andrzej Kudelka MD, FACP, FACE is recognized by Continental Who s Who prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press Release – New Zealand Government
The Government is acting to ensure decisions on responding to the next phase of the COVID-19 pandemic are informed by the best available scientific evidence and strategic public health advice.
“New Zealand has worked towards an elimination strategy which has been successful in keeping our people safe and our economy in good shape,” Minister for COVID-19 Response Chris Hipkins said.
“One of our strengths has been our commitment to constantly learn and adapt.
“The next phase of the pandemic poses significant challenges, including the emergence of new variants, but it also provides us with new opportunities,” Chris Hipkins said.
Covid 19 coronavirus: New advisory group to help Government with Covid decisions nzherald.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nzherald.co.nz Daily Mail and Mail on Sunday newspapers.
08/04/2021 COVID-19 Response Minister Chris Hipkins. Photo credit: Getty Images
The government has established a new scientific advisory group to advise it on crucial COVID-19 decisions, including any changes at the border and the ongoing vaccine rollout.
One of its first tasks will be to advise on a vaccine target.
The six person group will be headed by epidemiologist Professor Sir David Skegg, and will be in place until mid next year.
COVID-19 Response Minister Chris Hipkins said having the group was to ensure future decisions were informed by the best available scientific evidence and strategic public health advice .
That would include looking at vaccination rates and scenarios should the borders reopen, interpreting scientific data for any decisions around the border, public health protections and consideration of the residual risk of the non-immunised population and the associated health system capacity needs once the border s ope